Oxyhomologues of anandamide and related endolipids: Chemoselective synthesis and biological activity

Journal of Medicinal Chemistry

Volumn 49, Issue 7, 2006, Pages 2333-2338

  Appendino, Giovanni ^b   Minassi, Alberto ^b   Berton, Luca ^b   Moriello, Aniello Schiano ^a   Cascio, Maria Grazia ^a   De Petrocellis, Luciano ^a   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; HYDROXYLAMINE; N ACYLHYDROXYLAMINE; N OLEOYLETHANOLAMINE; O [2 (TERT BUTYLDIPHENYLSILYLOXY)ETHYL]HYDROXYLAMINE; PALMIDROL; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN HEK293; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDROGEN BOND; REACTION ANALYSIS; RECEPTOR AFFINITY; STRUCTURE ANALYSIS;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; CELL LINE; CERCOPITHECUS AETHIOPS; ETHANOLAMINES; HUMANS; HYDROLYSIS; HYDROXYLAMINES; PALMITIC ACIDS; POLYUNSATURATED ALKAMIDES; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; STRUCTURE-ACTIVITY RELATIONSHIP; TRPV CATION CHANNELS;

EID: 33645667347     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm051240y     Document Type: Article

References (31)

1. Schmid, P. C.; Zuzarte-Augustin, M. L.; Schmid, H. H. Properties of Rat Liver N-Acylethanolamine Amidohydrolase. J. Biol. Chem. 1985, 260, 1415-1419 and references therein.
2. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and Structure of a Brain Constituent that Binds to the Cannabinoid Receptor. Science 1992, 258, 1946-1949.
3. Wenk, M. R. The Emerging Field of Lipidomics. Nat. Rev. Drug Discov. 2005, 4, 594-610.
4. Huang, S. M.; Bisogno, T.; Trevisani, M.; Al-Hayani, A.; De Petrocellis, L.; Fezza, F.; Tognetto, M.; Petros, T. J.; Krey, J. F.; Chu, C. J.; Miller, J. D.; Davies, S. M.; Geppetti, P.; Walker, J. M.; Di Marzo, V. An Endogenous Capsaicin-Like Substance with High Potency at Recombinant and Native Vanilloid VR1 Receptors. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 8400-8405.
5. Chu, C. J.; Huang, S. M.; De Petrocellis, L.; Bisogno, T.; Ewing, S. A.; Miller, J. D.; Zipkin, R. E.; Daddario, N.; Appendino, G.; Di Marzo, V.; Walker, J. M. N-Oleoyldopamine, a Novel Endogenous Capsaicin-Like Lipid that Produces Hyperalgesia. J. Biol. Chem. 2003, 278, 13633-13639.
6. Guzman, M.; Lo Verme, J.; Fu, J.; Oveisi, F.; Blazquez, C.; Piomelli, D. Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-Activated Receptor alpha (PPAR-alpha). J. Biol. Chem. 2004, 279, 27849-27854.
7. LoVerme, J.; La Rana, G.; Russo, R.; Calignano, A.; Pomelli, D. The Search for the Palmitoylethanolamide Receptor. Life Sci. 2005, 77, 1685-1698.
8. Cravatt, B. F.; Prospero-Garcia, O.; Siuzdak, G.; Gilula, M. B.; Henriksen, S. J.; Boger, D. L.; Lerner, R. A. Chemical Characterization of a Family of Brain Lipids that Induce Sleep. Science 1995. 268, 1506-1509.
9. Di Marzo, V.; Bifulco, M.; De Petrocellis, L. The Endocannabinoid System and its Therapeutic Exploitation. Nat. Rev. Drug Discov. 2004, 3, 771-784.
10. For recent reviews, see: (a) Cravatt, B. F.; Lichtman, A. H. Fatty Acid Amide Hydrolase: an Emerging Therapeutic Target in the Endocannabinoid System. Curr. Opin. Chem. Biol. 2003, 7, 469-475.
11. (b) Bisogno, T.; De Petrocellis, L.; Di Marzo, V. Fatty Acid Amide Hydrolase, an Enzyme with many Bioactive Substrates. Possible Therapeutic Implications. Curr. Pharm. Des. 2002, 8, 533-547.
12. For a review, see: Di Marzo, V.; De Petrocellis, L.; Fezza, F.; Ligresti, A.; Bisogno, T. Anandamide Receptors. Prostaglandins Leukot. Essenti. Fatty Acids 2002, 66, 377-391.
13. The best known metabolically stable analogue of anandamide is (R)-meihanandamide, where a methyl group is introduced on the headgroup α-carbon (Abadji, V.; Lin, S.; Taha, G.; Griffin, G.; Stevenson, L. A.: Pertwee, R. G.; Makriyannis, A. (R)-Methanandamide, a Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability. J. Med. Chem. 1994, 37, 1889-1893).
14. For a review on the synthesis of endocannabinoids and related compounds, see: Razdan, R. K.; Mahadevan, A. Recent Advances in the Synthesis of Endocannabinoid Related Ligands. Chem. Phys. Lipids 2002, 121, 21-33.
15. (a) Khanolkar, A. D.; Abadji, V.; Lin, S.; Hill, W. A. G.; Taha, G.; Abouzid, K.; Meng, Z.; Fan, P.; Makriyannis, A. Head Group Analogs of Arachidonoylethanolamide, the Endogenous Cannabinoid Ligand. J. Med. Chem. 1996, 39, 4515-4519.
16. (b) Sheskin, T.; Hanus, L.; Slager, J.; Vogel, Z.; Mechoulam, R. Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor. J. Med. Chem. 1997, 40, 659-667.
17. (c) Lin, S.; Khanolkar, A. D.; Fan, P.; Goutopoulos, A.; Quin, C.; Papahatijs, D.; Makriyannis, A. Novel Analogues of Arachidonoylethanolamide (Anandamide): Affinities for the CB1 and CB2 Cannabinoid Receptors and Metabolic Stability. J. Med. Chem. 1998, 41, 5353-5361.
18. For reviews on the structure-activity relationships of endocannabinoids, see: (a) Martin, B. R.; Mechoulam, R.; Razdan, R. K. Discovery and Characterization of Endogenous Cannabinoids. Life Sci 1999, 65, 573-595.
19. (b) Khanolkar, A. D.; Makriyannis, A. Structure-Activity Relationships of Anandamide, an Endogenous Cannabinoid Ligand. Life Sci 1999, 65, 607-616.
20. (c) Palmer, S. L.; Khanolkar, A. D.; Makriyannis, A. Natural and Synthetic Endocannabinoids and their Structure-Activity Relationships. Curr. Pharm. Des. 2000, 6, 1381-1397.
21. (d) Reggio, P. H. Endocannabinoid Structure-Activity Relationships for Interaction at the Cannabinoid Receptors. Prostaglandins. Leukot. Essential Fatty Acids 2002, 66, 143-160.
22. Barnett-Norris, J.; Hurst, D. P.; Lynch, D. L.; Guarnieri, F.; Makriyannis, A.; Reggio, P. H. Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor. J. Med. Chem. 2002, 45, 3649-3659.
23. Yang, D.; Ng, F.-F.; Li, Z.-J.; Wu, Y.-D.; Chan, K. W. K.; Wang, D.-P. An Unusual Turn Structure in Peptides Containing α-Aminoxy Acids. J. Am. Chem. Soc. 1996, 118, 9794.
24. Maire, P.; Blandin, V.; Lopez, M.; Valléè, Y. Straightforward Synthesis of N-Hydroxy Peptides. Synlett 2003, 671-674.
25. Shin, I.; Lee, M.; Lee, J.; Jung, M.; Lee, W.; Yoon, J. Synthesis of Optically Active Phthaloyl D-Aminooxy Acids from L-Amino Acids or L-Hydroxy Acids as Building Blocks for the Preparation of Aminooxy Pepetides. J. Org. Chem. 2000, 65, 7667-7675.
26. Kende, A. S.; Mendoza, J. S. Controlled Reduction to Nitroalkanes to Alkyl Hydroxylamines or Amines by Samarium Diiodide. Tetrahedron Lett. 1991, 32, 1699-1991.
27. Appendino, G.; Minassi, A.; Morello, A. S.; De Petrocellis, L.; Di Marzo, V. N-Acylvanillamides: Development of an Expeditious Synthesis and Discovery of New Acyl Templates for Powerful Activation of the Vanilloid Receptor. J. Med. Chem. 2002, 45, 3739-3745.
28. Ech-Chahad, A.; Minassi, A.; Berton, L.; Appendino, G. An Expeditious Hydroxyamidation of Carboxylic Acids. Tetrahedron Lett. 2005, 46, 5113-5115.
29. Appendino, G.; Muñoz, E.; Fiebich, B. L. TRPVI (Vanilloid Receptor, Capsaicin Receptor) Agonists and Antagonists. Exp. Opin. Ther. Pat. 2003, 13, 1825-18.
30. Cabranes, A.; Venderova, K.; de Lago, E.; Fezza, F.; Sanchez, A.; Mestre, L.; Valenti, M.; Garcia-Merino, A.; Ramos, J. A.; Di Marzo, V.; Fernandez-Ruiz, J. Decreased Endocannabinoid Levels in the Brain and Beneficial Effects of Agents Activating Cannabinoid and/or Vanilloid Receptors in a Rat Model of Multiple Sclerosis. Neurobiol. Dis. 2005, 20, 207-217.
31. Anderson, N. G.; Lust, D. A.; Colapret, K. A.; Simpson, J. H.; Malley, M. F.; Gougoutas, J. Z. Sulfonilation with inversion by Mitsunobu Reaction: An Improvement on the Original Conditions. J. Org. Chem. 1996, 61, 7955-7958.